CD8A and neoplasm: This result was validated by cell type–level expression analysis from GEPIA 2021 (http://gepia2021.cancer-pku.cn) comparing RIG-I expression between tumor-infiltrating CD8+ T cells and CD8+ T cells in the relevant normal tissues (Supplemental Figure 8A).